Glass House Brands (GLASF) Q3 2025 earnings summary

Executive summary

• Q3 2025 was marked by significant operational disruption due to federal raids and labor compliance overhauls, resulting in a planned scale-back in planting and production and a temporary setback in operations.

• Retail and CPG segments achieved strong year-over-year growth, outperforming the broader California market, with Allswell becoming a top 3 California flower brand by unit sales.

• The company operates the largest cannabis cultivation footprint in California, with up to 6 million sq. ft. of facilities and a vertically integrated model.

• Recent milestones include refinancing senior secured debt with a new $50M loan maturing in 2030 and becoming the first U.S. plant-touching cannabis company listed on Robinhood.

• The company expects to return to full production capacity in Q1 2026, with record acreage planted by year-end 2025.

Financial highlights

• Q3 2025 revenue was $38.4M, down from $63.8M YoY and $59.9M sequentially; retail sales up 13% YoY, outperforming the state by 23%.

• Gross profit margin was 31%, down from 52% YoY and 53% sequentially; adjusted EBITDA was -$2.3M, down from $20.4M YoY and $18.1M sequentially.

• Operating cash flow was -$5.1M vs. $13.2M YoY and $17.7M sequentially; cash and restricted cash at quarter-end was $26.3M.

• Average selling price for biomass was $155/lb, down from $229 YoY and $206 sequentially; cost of production rose to $128/lb.

• Q3 2025 net loss was $12.2M, following net income of $8.7M in Q2 2025.

Outlook and guidance

• Q4 2025 revenue expected between $37M-$39M, with wholesale segment continuing to face headwinds.

• Full-year 2025 revenue now guided to $180M-$182M (down from $190M-$195M prior), gross margin at 41%, and adjusted EBITDA at $14M-$16M.

• Full production capacity expected in Q1 2026, with record acreage planted by year-end 2025 and long-term production cost target of $95/lb.

• Expansion of Greenhouse 2 is underway, with full buildout expected in 2026.

• Management anticipates continued impact from lower volumes and quality into Q4 2025 but expects recovery as legacy product processing completes.